Related Experiment Video
Updated: Mar 26, 2026

07:31
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
4.4K
Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression
Heng Zeng1, Jin-Ming Zhang1, Yu Du1,2
1Department of Orthopedics, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Oncotarget
|January 23, 2016
Summary
Activating transcription factor 4 (ATF4) drives osteosarcoma progression and metastasis. Targeting ATF4 may offer a new therapeutic strategy for this bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Activating transcription factor 4 (ATF4) is a stress response gene implicated in cancer.
- Osteosarcoma (OS) is a primary bone cancer with a high propensity for metastasis.
Purpose of the Study:
- To investigate the role of ATF4 in osteosarcoma progression and metastasis.
- To explore the relationship between ATF4, metastasis-associated protein 1 (MTA1), and histone deacetylase 1 (HDAC1) in OS.
Main Methods:
- Analysis of ATF4 expression in OS cell lines and patient samples.
- In vitro studies involving ATF4 overexpression and knockdown of MTA1/HDAC1.
- In vivo studies using mouse models of osteosarcoma.
Main Results:
- ATF4 is upregulated in OS and promotes cell proliferation, migration, and lung metastasis.
- MTA1 and HDAC1 regulate ATF4 stability and activity, forming a positive feedback loop.
- ATF4 expression correlates with MTA1 levels in patients and enhances tumor growth in vivo.
Conclusions:
- ATF4 plays a critical role in osteosarcoma progression and metastasis through its interaction with MTA1/HDAC1.
- Targeting ATF4 presents a potential therapeutic avenue for osteosarcoma treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression
1.7K
1.7K
PI3K/mTOR/AKT Signaling Pathway
6.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.3K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K

